查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
人造器官的全球市場
市場調查報告書
商品編碼
1194097

人造器官的全球市場

Artificial Organs
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 288 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球人造器官的市場規模預測將從2022年的216億美元，到2030年達到389億美元，在2022年～2030年的分析期間預計將以7.7％的年複合成長率擴大。

本報告提供全球人造器官市場相關調查分析，提供市場趨勢與推動因素，預測，地區分析，競爭情形等資訊。

調查對像企業範例(全71公司):

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

第4章 競爭

簡介目錄
Product Code: MCP-1126

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Artificial Organs Market to Reach $38.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Artificial Organs estimated at US$21.6 Billion in the year 2022, is projected to reach a revised size of US$38.9 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2022-2030. Artificial Kidneys, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$20.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Artificial Pancreas segment is readjusted to a revised 7.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.3 Billion, While China is Forecast to Grow at 7.1% CAGR

The Artificial Organs market in the U.S. is estimated at US$6.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2030 trailing a CAGR of 7.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 6.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Select Competitors (Total 71 Featured):

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Recent Market Activity
    • Artificial Organs Revolutionize Medical Industry
    • Growth Drivers
    • Growth Inhibitors
    • Artificial Organs Poised to Witness Significant Demand
    • The United States - A Dominant Force in the Artificial Organs Market
    • Artificial Kidneys Garner a Larger Pie in the Artificial Organs Market
    • Demand and Supply Imbalance
    • Competitive Scenario
    • Technological Advancements Spearheading Growth
    • Artificial Organs - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • ABBOTT (USA)
    • Abiomed, Inc. (USA)
    • Asahi Kasei Medical Co., Ltd. (Japan)
    • Baxter International, Inc. (USA)
    • F.Hoffmann-La Roche Ltd. (Switzerland)
    • Fresenius Medical Care AG & Co. KGaA (Germany)
    • Jarvik Heart, Inc. (USA)
    • Medtronic, Inc. (USA)
    • HeartWare International, Inc. (USA)
    • Nikkiso Co., Ltd. (Japan)
    • Nipro Corporation (Japan)
    • SynCardia Systems, LLC (USA)
    • Toray Medical Co., Ltd. (Japan)
    • Xenios AG (Germany)
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Cardiovascular Disease Drive the Market for Artificial Heart and VAD
    • Higher Development Costs and Lengthy Regulatory Process - Stumbling Blocks for Product Commercialization
    • Lack of Requisite Expertise - Hindering Implantation Process
    • Xenotransplantation - Other Alternative to Donor Organ Shortage
    • Artificial Organs from Cloned Animal Cells - A Promising Trend
    • Immunosuppressants Hold Promise in Artificial Organs Market
    • Move towards Smaller Implantable Devices
    • Barriers to Entry Significantly High in Dialyzers Market
    • Reuse of Dialyzers - A Major Issue in Dialysis Industry
    • Poor Reimbursement Environment Stymies Innovation
    • Product Recalls - A Major Blow to the Manufacturers
    • Higher Cost of Artificial Organs Hampers Broader Adoption
    • Major Issues Related to Artificial Organs
    • Financial
    • Legal
    • Ethical
    • Social
    • UCLA Researchers Develop Cancer-Fighting Cells
    • Production of 3D-like Artificial Organs in a Device that Works like a Cotton Candy Machine
    • Harvard Scientists Create Tissue Containing Blood Vessels
    • University of Washington Researchers Create Communicating Yeast Cells
    • Scientists Define Morphospace to Evaluate Viability of Artificial Organs
    • Application of 3D-Printing in the Medical Field
    • 3D Printing Revolutionizing the Medical Industry's Artificial Organ Development Segment
    • "Soft" 3D Bioprinting Eliminates Concerns of Hard Plastic-based Organ Models
    • 3D Printed Organ Models with Sensors Enable Real-time Feedback
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Artificial Kidneys by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Artificial Pancreas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Artificial Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Artificial Lungs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Artificial Organs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • JAPAN
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • CHINA
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: China 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • EUROPE
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • FRANCE
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: France 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • GERMANY
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 56: Rest of World Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Rest of World Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Rest of World 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2023 & 2030

IV. COMPETITION